ide case" style="--ca:#4A7C8E;">
5110869 林○惠 F/40 VS 李岳聰醫師乳癌
Cancer of breast, Lt, cT2N1M0 stage:IIA, pT2N1aM0 stage:IIB, ER 50%、PR 90%、HER2 2+ / FISH(-)、Ki-67 40%
現病史Left breast mass
過去病史liver hemangioma, GB sludges, hyperlipidemia, Rt ovarian lesion favored benign
家族史無
病理2026-03-30： Lt breast mass, core biopsy: IDC, Gr1, score:5, lv(-), pn(-), ER(+)80%, PR(+)80%, HER2 0, Ki-67 20%, p63(-), CK5/6(+), E-cadherin(+)2026-04-22： Lt nipple-sparing total mastectomy, SNBx: IDC, Gr2, score:6, T:single, 35x30x25 mm, EIC(+), DCIS 15 mm GII, microCal(+), lv(+), pn(-), margin free, SN:1/1, ER(+)50%, PR(+)90%, HER2 2+, FISH(-), Ki-67 40%, pT2N1a
檢查SONO(2026-03-21)
Fatty liver, liver masses, mild bilateral hydronephrosis, GB debrisMammography(2026-03-28)
Left upper outer breast ill-defined lesion about 3.0 cm with architectural distortion, BI-RADS 4CBreast SONO(2026-03-31)
Left breast irregular hypoechoic mass 2.8x2.0 cm with microcalcifications; bilateral mammary duct dilatation, BI-RADS 4/5PET-CT(2026-04-08)
FDG-avid lesion in left breast; left axillary level II lymph node suspicious for metastasis; right adnexal lesion favored benign; no distant metastasis; staging T1cN1?M0, stage IIA
治療Lt nipple-sparing total mastectomy + SNBx + Rt port-A + immediate reconstruction(2026-04-21)
Endoscopic nipple-sparing total mastectomy with tissue expander implantation adjuvant chemotherapy(2026-05-12)
EC（Epirubicin 80 mg + Cyclophosphamide 700 mg）
討論2026/05/12 開始 adjuvant chemotherapy with EC（80 mg/700 mg），後續建議轉介放射腫瘤科評估 PMRT/RNI 並說明對重建乳房可能影響，完成化放療後接續 endocrine therapy。
1/1
5110869 林○惠乳房攝影
2026-03-28
Findings: Left upper outer breast ill-defined 3.0 cm lesion with architectural distortion. Right breast unremarkable.
Impression: BI-RADS 4C, suspicious abnormality, biopsy recommended.
mammo1
mammo2
5110869 林○惠手術照片
手術1
手術1
手術2
手術2
5110869 林○惠手術照片
手術3
手術3
手術4
手術4
5110869 林○惠手術照片
手術5
手術5
手術6
手術6
乳癌多專科團隊會議 — 2026-05-28
乳癌多專科團隊會議
2026年5月28日(星期四)  07:30-08:30
彰濱-1F 人文藝術館會議室
聯絡人：郭美伶(17379)
乳癌　召集人：李岳聰醫師　核心成員：一般外科吳鴻昇醫師、林建華醫師；影像診斷科葉偉成醫師；病理科賴義雄醫師；核醫科侯柏年醫師；放射腫瘤科熊敬業醫師；血液腫瘤科張正雄醫師
乳癌
2026年5月28日(星期四)
5110869 林○惠 F/40 VS 李岳聰醫師乳癌
Cancer of breast, Lt, cT2N1M0 stage:IIA, pT2N1aM0 stage:IIB, ER 50%、PR 90%、HER2 2+ / FISH(-)、Ki-67 40%
現病史Left breast mass
過去病史liver hemangioma, GB sludges, hyperlipidemia, Rt ovarian lesion favored benign
家族史無
病理2026-03-30： Lt breast mass, core biopsy: IDC, Gr1, score:5, lv(-), pn(-), ER(+)80%, PR(+)80%, HER2 0, Ki-67 20%, p63(-), CK5/6(+), E-cadherin(+)2026-04-22： Lt nipple-sparing total mastectomy, SNBx: IDC, Gr2, score:6, T:single, 35x30x25 mm, EIC(+), DCIS 15 mm GII, microCal(+), lv(+), pn(-), margin free, SN:1/1, ER(+)50%, PR(+)90%, HER2 2+, FISH(-), Ki-67 40%, pT2N1a
檢查SONO(2026-03-21)
Fatty liver, liver masses, mild bilateral hydronephrosis, GB debrisMammography(2026-03-28)
Left upper outer breast ill-defined lesion about 3.0 cm with architectural distortion, BI-RADS 4CBreast SONO(2026-03-31)
Left breast irregular hypoechoic mass 2.8x2.0 cm with microcalcifications; bilateral mammary duct dilatation, BI-RADS 4/5PET-CT(2026-04-08)
FDG-avid lesion in left breast; left axillary level II lymph node suspicious for metastasis; right adnexal lesion favored benign; no distant metastasis; staging T1cN1?M0, stage IIA
治療Lt nipple-sparing total mastectomy + SNBx + Rt port-A + immediate reconstruction(2026-04-21)
Endoscopic nipple-sparing total mastectomy with tissue expander implantation adjuvant chemotherapy(2026-05-12)
EC（Epirubicin 80 mg + Cyclophosphamide 700 mg）
討論2026/05/12 開始 adjuvant chemotherapy with EC（80 mg/700 mg），後續建議轉介放射腫瘤科評估 PMRT/RNI 並說明對重建乳房可能影響，完成化放療後接續 endocrine therapy。
1/1
5110869 林○惠乳房攝影
2026-03-28
Findings: Left upper outer breast ill-defined 3.0 cm lesion with architectural distortion. Right breast unremarkable.
Impression: BI-RADS 4C, suspicious abnormality, biopsy recommended.
mammo1
mammo2
5110869 林○惠手術照片
手術1
手術1
手術2
手術2
5110869 林○惠手術照片
手術3
手術3
手術4
手術4
5110869 林○惠手術照片
手術5
手術5
手術6
手術6
1 / 7